Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Conclusion: Both contraceptives improved dysmenorrhoea and chronic pelvic pain scores in women with endometriosis-associated pain and they reduced serum levels of soluble CD23; however, serum levels of CA-125 were reduced only in ENG implant users over the 24-month study period.
PMID: 32069126 [PubMed - as supplied by publisher]
Source: The European Journal of Contraception and Reproductive Health Care - Category: Reproduction Medicine Authors: Margatho D, Carvalho NM, Bahamondes L Tags: Eur J Contracept Reprod Health Care Source Type: research
More News: Brazil Health | Chronic Pain | Endometriosis | Health Management | Mirena | Pain | Reproduction Medicine | Study | Women